Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of hemoporfin photodynamic therapy for port-wine stain
ChiCTR-TRC-08000213Phase 3Completed
- Sponsor
- Peking University First Hospital
- Start
- Sep 2008
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of hemoporfin in port-wine stain (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Third party assessment. Started Sep 2008; status: completed.
02
Drugs
hemoporfin
03
Conditions
port-wine stain
Beyond the preview
Go deeper on ChiCTR-TRC-08000213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000213.